Creatine monohydrate is the most extensively studied sports supplement in history, with over 1,000 peer-reviewed publications. Its effects on strength, power, and lean mass are among the most robustly established in exercise science. But creatine's emerging evidence for cognitive function, depression, brain injury neuroprotection, and sarcopenia prevention in older adults makes it relevant far beyond the gym — and positions it as one of the most evidence-backed longevity supplements available.
Creatine monohydrate has over 1,000 peer-reviewed publications behind it — more than any other performance supplement and more than most pharmaceutical agents. Its effects on phosphocreatine availability, high-intensity exercise performance, and resistance training adaptations have been established in repeated RCTs across diverse populations. What has changed in the past decade is recognition that creatine's benefits extend substantially beyond athletic performance into aging biology, cognitive function, and neurological health — making it one of the most broadly evidence-backed supplements in the longevity context.1
Creatine (methyl guanidine-acetic acid) is synthesized endogenously in the liver, kidneys, and pancreas from arginine and glycine, with methionine providing the methyl group. Approximately 95 percent of the body's creatine is found in skeletal muscle, primarily as phosphocreatine (PCr). The creatine kinase reaction — PCr + ADP → Creatine + ATP — provides an immediate energy buffer for ATP resynthesis during the first 5 to 10 seconds of maximal effort, before the glycolytic and oxidative systems can increase their contribution. This buffering capacity is what underlies creatine's well-established effects on high-intensity exercise performance.2
Dietary creatine comes primarily from meat and fish — approximately 3 to 5 grams of creatine per kilogram of raw meat. This means vegetarians and vegans have significantly lower baseline muscle creatine stores than omnivores, and show larger relative responses to creatine supplementation (as the supplemented creatine fills a larger baseline deficit).
The most longevity-relevant application of creatine in aging populations is its enhancement of resistance training adaptations. Multiple RCTs in adults over 55 have found that creatine supplementation (5 g/day) combined with resistance training produces significantly greater gains in lean muscle mass, muscle strength (bench press, leg press), and functional performance (chair stand, stair climbing) than resistance training plus placebo. A 2017 meta-analysis of 22 RCTs in older adults found that creatine supplementation plus resistance training produced a 1.37 kg greater increase in lean mass compared to resistance training alone.3
The mechanism: creatine supplementation increases satellite cell activity during exercise — the muscle stem cells that fuse with existing muscle fibers to add myonuclei and support hypertrophy. Higher myonuclear density is associated with greater hypertrophic capacity and better maintenance of muscle mass with aging. Creatine also reduces muscle protein breakdown during exercise by maintaining ATP availability and reducing exercise-induced metabolic stress.
The brain is one of the most energetically demanding organs in the body, consuming approximately 20 percent of total energy despite comprising only 2 percent of body weight. Creatine's PCr system is relevant in neuronal energy metabolism — particularly during cognitive tasks requiring intense mental effort or during conditions of reduced brain energy availability (sleep deprivation, hypoxia, aging).4
A 2023 meta-analysis of 10 RCTs evaluating creatine's effects on cognitive function in healthy individuals found significant improvements in memory tasks, with the largest effects in older adults and in sleep-deprived individuals. The memory benefit was not seen consistently across all cognitive domains — it appears strongest for tasks with high working memory and executive function demands. These are precisely the cognitive domains that decline most prominently with aging, making creatine's potential cognitive protection particularly relevant for longevity purposes.
Three decades of RCT evidence have not established any clinically meaningful adverse effects of creatine supplementation at standard doses in healthy adults. The kidney concern — which persists in public perception despite the evidence — derives from the fact that creatine supplementation increases serum creatinine (a metabolite of creatine clearance used to estimate GFR). However, multiple studies have confirmed that creatine supplementation does not impair actual GFR, kidney tubular function, or kidney structural integrity in healthy adults. In individuals with pre-existing kidney disease, consultation with a physician is appropriate before initiating supplementation.5
Creatine monohydrate causes transient water retention (approximately 0.5 to 1.5 kg, primarily intramuscular) during the first 1 to 2 weeks of supplementation, which can be misinterpreted as fat gain. This water retention is intramuscular (not subcutaneous edema) and is actually a marker of successful muscle creatine loading. It reverses within 1 to 2 weeks of stopping supplementation.
